US 8288537
Caspase inhibitors and uses thereof
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8288537 (Caspase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/14, A61P1/16